Molecular characteristics of pediatric nasopharyngeal carcinoma using whole-exome sequencing

被引:1
作者
Wu, Bian [1 ]
Shen, Liangfang [2 ]
Peng, Gang [1 ]
Li, Yingqiang [3 ]
Zhou, Zhiyuan [1 ]
Li, Jingao [4 ]
Huang, Xiaodong [5 ]
Zhou, Qin [2 ]
Jiang, Hongguo [3 ]
Huang, Jing [1 ]
Ding, Qian [1 ]
Zhang, Zhanjie [1 ]
Qin, You [1 ]
Hong, Xiaohua [1 ]
Shi, Liangliang [1 ]
Zou, Zhenwei [1 ]
Yao, Jing [1 ]
Zhang, Jing [3 ]
Liu, Danni [3 ]
Wan, Chao [1 ]
Wu, Gang [1 ]
Song, Lele [3 ]
Chen, Shifu [3 ]
Yi, Junlin [5 ]
Yang, Kunyu [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan 430022, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Dept Oncol, Changsha, Peoples R China
[3] HaploX Biotechnol, Shenzhen, Peoples R China
[4] Nanchang Univ, Dept Radiotherapy, Jiangxi Canc Hosp, Nanchang, Peoples R China
[5] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Dept Radiat Oncol,Natl Clin Res Ctr Canc, Beijing, Peoples R China
关键词
Pediatric nasopharyngeal carcinoma; Rare cancer; Pediatric cancer; Whole exome sequencing; EPSTEIN-BARR-VIRUS; ANTITUMOR-ACTIVITY; CANCER; MUTATIONS; CHILDREN; RISK; LANDSCAPE; RECURRENT; ANTIBODY; FEATURES;
D O I
10.1016/j.oraloncology.2022.106218
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: While a number of genetic and epigenetic events contributing to adult nasopharyngeal carcinomas (aNPC) development has been established, the scarcity of pediatric nasopharyngeal carcinoma (pNPC) hinders the understanding of the biology of the disease and rational treatment approach. We aim to identify the mo-lecular characteristics of pNPC.Materials and Methods: pNPC primary tumors with paired blood samples were collected and sequenced using whole-exome sequencing. Samples were collected from four tertiary academic medical centers in China. A total of 30 patients (25 male and 5 female) with pathologically confirmed NPC under the age of 20 were enrolled.Results: Several genes such as C9orf84 (20 %), ZFHX4 (16.7 %), ZC3H6 (16.7 %), RBM38 (16.7 %) were frequently mutated in pNPC. Copy number analysis revealed highly recurring gain/amplification of the HLA class II genes at 6p21.32 (63.3 %) and losses of TOLLIP at 11p15.5 (20 %). Recurrent NUTM1 (16.7 %) fusion variants were found for the first time with pNPC. We also investigated germline genomic signatures and showed 8 of 30 (26.7 %) of the pNPC patients carrying germline pathogenic and/or likely pathogenic variants in known cancer -predisposing genes. Multi-dimensional comparison suggested that pNPC might exhibit distinct genomic profile compared to aNPC. In addition, pNPC exhibited significantly elevated level of PD-L1 expression than aNPC (percent of patients with >50 % PD-L1 expression: 92.0 % vs 32.1 %), suggesting high possibility of benefit from immunotherapy.Conclusion: Our results provide the first insight into the molecular basis of pNPC, and might offer novel targets and therapeutic approaches such as immunotherapy for this rare disease.
引用
收藏
页数:8
相关论文
共 41 条
[1]   Signatures of mutational processes in human cancer [J].
Alexandrov, Ludmil B. ;
Nik-Zainal, Serena ;
Wedge, David C. ;
Aparicio, Samuel A. J. R. ;
Behjati, Sam ;
Biankin, Andrew V. ;
Bignell, Graham R. ;
Bolli, Niccolo ;
Borg, Ake ;
Borresen-Dale, Anne-Lise ;
Boyault, Sandrine ;
Burkhardt, Birgit ;
Butler, Adam P. ;
Caldas, Carlos ;
Davies, Helen R. ;
Desmedt, Christine ;
Eils, Roland ;
Eyfjord, Jorunn Erla ;
Foekens, John A. ;
Greaves, Mel ;
Hosoda, Fumie ;
Hutter, Barbara ;
Ilicic, Tomislav ;
Imbeaud, Sandrine ;
Imielinsk, Marcin ;
Jaeger, Natalie ;
Jones, David T. W. ;
Jones, David ;
Knappskog, Stian ;
Kool, Marcel ;
Lakhani, Sunil R. ;
Lopez-Otin, Carlos ;
Martin, Sancha ;
Munshi, Nikhil C. ;
Nakamura, Hiromi ;
Northcott, Paul A. ;
Pajic, Marina ;
Papaemmanuil, Elli ;
Paradiso, Angelo ;
Pearson, John V. ;
Puente, Xose S. ;
Raine, Keiran ;
Ramakrishna, Manasa ;
Richardson, Andrea L. ;
Richter, Julia ;
Rosenstiel, Philip ;
Schlesner, Matthias ;
Schumacher, Ton N. ;
Span, Paul N. ;
Teague, Jon W. .
NATURE, 2013, 500 (7463) :415-+
[2]   Childhood nasopharyngeal carcinoma: from biology to treatment [J].
Ayan, I ;
Kaytan, E ;
Ayan, N .
LANCET ONCOLOGY, 2003, 4 (01) :13-21
[3]   DNA mismatch repair in cancer [J].
Baretti, Marina ;
Le, Dung T. .
PHARMACOLOGY & THERAPEUTICS, 2018, 189 :45-62
[4]   Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma [J].
Bauer, Daniel E. ;
Mitchell, Chelsey M. ;
Strait, Kelly M. ;
Lathan, Christopher S. ;
Stelow, Edward B. ;
Lueer, Sonja C. ;
Muhammed, Somala ;
Evans, Andrew G. ;
Sholl, Lynette M. ;
Rosai, Juan ;
Giraldi, Eugenia ;
Oakley, Richard P. ;
Rodriguez-Galindo, Carlos ;
London, Wendy B. ;
Sallan, Stephen E. ;
Bradner, James E. ;
French, Christopher A. .
CLINICAL CANCER RESEARCH, 2012, 18 (20) :5773-5779
[5]   Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults [J].
Buehrlen, Martina ;
Zwaan, Christian Michel ;
Granzen, Bernd ;
Lassay, Lisa ;
Deutz, Peter ;
Vorwerk, Peter ;
Staatz, Gundula ;
Gademann, Guenther ;
Christiansen, Hans ;
Oldenburger, Foppe ;
Tamm, Miriam ;
Mertens, Rolf .
CANCER, 2012, 118 (19) :4892-4900
[6]   Update in pediatric nasopharyngeal undifferentiated carcinoma [J].
Claude, Line ;
Jouglar, Emmanuel ;
Duverge, Loig ;
Orbach, Daniel .
BRITISH JOURNAL OF RADIOLOGY, 2019, 92 (1102)
[7]   A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32 [J].
Cozen, Wendy ;
Li, Dalin ;
Best, Timothy ;
Van den Berg, David J. ;
Gourraud, Pierre-Antoine ;
Cortessis, Victoria K. ;
Skol, Andrew D. ;
Mack, Thomas M. ;
Glaser, Sally L. ;
Weiss, Lawrence M. ;
Nathwani, Bharat N. ;
Bhatia, Smita ;
Schumacher, Fredrick R. ;
Edlund, Christopher K. ;
Hwang, Amie E. ;
Slager, Susan L. ;
Fredericksen, Zachary S. ;
Strong, Louise C. ;
Habermann, Thomas M. ;
Link, Brian K. ;
Cerhan, James R. ;
Robison, Leslie L. ;
Conti, David V. ;
Onel, Kenan .
BLOOD, 2012, 119 (02) :469-475
[8]   NUTM1 Gene Fusions Characterize a Subset of Undifferentiated Soft Tissue and Visceral Tumors [J].
Dickson, Brendan C. ;
Sung, Yun-Shao ;
Rosenblum, Marc K. ;
Reuter, Victor E. ;
Harb, Mohammed ;
Wunder, Jay S. ;
Swanson, David ;
Antonescu, Cristina R. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2018, 42 (05) :636-645
[9]   Childhood Nasopharyngeal Carcinoma: State-of-the-Art, and Questions for the Future [J].
Dourthe, Marie-Emilie ;
Bolle, Stephanie ;
Temam, Stephane ;
Jouin, Anais ;
Claude, Line ;
Reguerre, Yves ;
Defachelles, Anne-Sophie ;
Orbach, Daniel ;
Fresneau, Brice .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (02) :85-92
[10]   Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials [J].
Fang, Wenfeng ;
Yang, Yunpeng ;
Ma, Yuxiang ;
Hong, Shaodong ;
Lin, Lizhu ;
He, Xiaohui ;
Xiong, Jianping ;
Li, Ping ;
Zhao, Hongyun ;
Huang, Yan ;
Zhang, Yang ;
Chen, Likun ;
Zhou, Ningning ;
Zhao, Yuanyuan ;
Hou, Xue ;
Yang, Qing ;
Zhang, Li .
LANCET ONCOLOGY, 2018, 19 (10) :1338-1350